Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Shumen

26 clinical trials in Shumen, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Shumen at a glance
26
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

26 trials in Shumen

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Bladder cancer

Recruiting

Long‑Term Follow‑Up of Mitomycin (UGN‑103) Treatment in Patients with Recurrent Low‑Grade Intermediate‑Risk Non‑Muscle Invasive Bladder Cancer

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.

Breast cancer+2

Recruiting

Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vidofludimus Calcium
  • Sponsor:Immunic AG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.

Fallopian tube cancer+1

Not yet recruiting

Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

A Study of Inhaled Fexlamose for Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE
  • Sponsor:Aer Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Shumen

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and stroke prevention in patients with atrial fibrillation. Researchers are evaluating novel therapeutic combinations to reduce cardiovascular mortality and improve patient outcomes.

  • Heart Failure Prevention
  • Stroke Prevention
  • Cardiac Disease Management

New treatment approaches combining established medications with experimental compounds show promise in reducing cardiovascular events.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on breast cancer and bladder cancer treatments. Multiple trials are investigating targeted therapies for both early-stage and metastatic disease.

  • Breast Cancer Therapeutics
  • Bladder Cancer Treatment
  • Cancer Cachexia Management

Advanced therapeutic approaches including combination treatments and targeted molecular therapies are being evaluated.

03 Neurological Disorders

Groundbreaking research in treating progressive multiple sclerosis, focusing on innovative therapies to slow disease progression and improve patient outcomes. Studies utilize advanced imaging techniques to measure treatment effectiveness.

  • Multiple Sclerosis Treatment
  • Brain Atrophy Assessment
  • Neurological Disease Management

Novel therapeutic approaches are being tested to address progressive forms of MS.

04 Pain Management

Advanced research in postoperative pain management, exploring innovative delivery systems for pain medication. Studies focus on developing more effective pain relief strategies following surgical procedures.

  • Post-Surgery Pain Control
  • Novel Drug Delivery Systems
  • Pain Relief Optimization

Investigations into nasal spray applications for immediate post-surgical pain relief.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.